Lubov Blumkin
-
- Genetic Neurodegenerative Diseases 5
- Neuroscience and Neuropharmacology Research 3
- Psychiatry and Mental health top 10%
- Epilepsy research and treatment 4
-
- Neurological diseases and metabolism 5
- Autoimmune Neurological Disorders and Treatments 4
-
- Neurological diseases and metabolism 5
- Autoimmune Neurological Disorders and Treatments 4
-
- Fetal and Pediatric Neurological Disorders 6
-
- Mitochondrial Function and Pathology 6
- RNA regulation and disease 6
- Co-authors
- Tally Lerman‐SagieDorit LevEsther Leshinsky‐SilverSara KivityKeren YosovichMarina MichelsonAyelet ZeremIlan Linder
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Lubov Blumkin
29 papers receiving 493 citations
Peers
Comparison fields: 5 of 58
- Cellular and Molecular Neuroscience 161
- Psychiatry and Mental health 101
- Neurology 50
- Neurology 90
- Pediatrics, Perinatology and Child Health 87
Countries citing papers authored by Lubov Blumkin
This map shows the geographic impact of Lubov Blumkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubov Blumkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubov Blumkin more than expected).
Fields of papers citing papers by Lubov Blumkin
This network shows the impact of papers produced by Lubov Blumkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubov Blumkin. The network helps show where Lubov Blumkin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lubov Blumkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 2 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 12 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 4 | |
| 7 | 2019 | 3 | |
| 8 | 2019 | 16 | |
| 9 | 2016 | 22 | |
| 10 | 2015 | 10 | |
| 11 | 2015 | 31 | |
| 12 | 2014 | 7 | |
| 13 | 2014 | 31 | |
| 14 | 2013 | 34 | |
| 15 | 2012 | 35 | |
| 16 | 2012 | 46 | |
| 17 | 2011 | 11 | |
| 18 | 2011 | 25 | |
| 19 | 2007 | 23 | |
| 20 | 2007 | 5 |
About Lubov Blumkin
Lubov Blumkin is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology, having authored 31 papers that have together received 502 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (6 papers), RNA regulation and disease (6 papers), Fetal and Pediatric Neurological Disorders (6 papers), Neurological diseases and metabolism (5 papers), Genetic Neurodegenerative Diseases (5 papers), Autoimmune Neurological Disorders and Treatments (4 papers), Epilepsy research and treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (161 citations), Psychiatry and Mental health (101 citations) and Neurology (50 citations). Lubov Blumkin has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Tally Lerman‐Sagie, Dorit Lev, Esther Leshinsky‐Silver, Sara Kivity, Keren Yosovich, Marina Michelson, Ayelet Zerem, Ilan Linder, Nathan Watemberg and Sarit Cohen. Their work appears in journals such as PEDIATRICS, Epilepsia and Journal of the Neurological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.